Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance
Go back to Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance| (NASDAQ: AVDL) | Delayed: 21.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.64 | 52 Week High | $ | |||
| Open | $21.64 | 52 Week Low | $ | |||
| Day High | $21.64 | P/E | N/A | |||
| Day Low | $21.64 | EPS | $ | |||
| Volume | 55 | |||||

